Trial Profile
Randomised Open-Label Multicenter Prosp. Clinical Study to Show the Efficacy of IV ZOMETA 4mg for Prevention of Bone Metastases in Hormone-naive High Risk Patients With Locally Advanced Prostate Cancer.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 05 Jun 2009 New trial record.